Log in to save to my catalogue

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C...

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2716a4168f93444f950e751fa2b2f7b4

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes

About this item

Full title

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes

Publisher

BP, Asia: Wiley Publishing Asia Pty Ltd

Journal title

The Kaohsiung journal of medical sciences, 2022-09, Vol.38 (9), p.897-906

Language

English

Formats

Publication information

Publisher

BP, Asia: Wiley Publishing Asia Pty Ltd

More information

Scope and Contents

Contents

Hepatitis C virus (HCV) eradication through antivirals ameliorates metabolic profiles. The changes in 2‐h plasma glucose (2HPG) levels by oral glucose tolerance test (OGTT), in chronic hepatitis C (CHC) patients who receive directly acting antivirals (DAAs) was elusive. Five hundred and thirty‐three CHC patients who achieved sustained virological r...

Alternative Titles

Full title

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2716a4168f93444f950e751fa2b2f7b4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2716a4168f93444f950e751fa2b2f7b4

Other Identifiers

ISSN

1607-551X

E-ISSN

2410-8650

DOI

10.1002/kjm2.12563

How to access this item